News

Crown CRO becomes part of the Optimapharm family

We are very excited to announce the acquisition of Crown CRO by Optimapharm d.o.o. The relationship between Optimapharm and Crown CRO is already built on a strong foundation of existing collaboration that started nearly 10 years ago. This acquisition gives Crown CRO’s existing and future customers access to a Pan-European footprint with direct access to […]

Read more

Crown CRO and Medical Writer Ada MacKeith part of University of Helsinki HITP group mentoring programme

In 2019 the University of Helsinki launched the HelsinkiUNI International Talent Programme (HITP), a group mentoring programme that connects international students with local companies and organisations. Crown CRO’s Medical Writer and University of Helsinki alumna Ada MacKeith took part as a mentor for students on the TRANSMED programme.

Read more

We are seeking a Medical Writing Document Manager in Finland

Crown CRO Oy is looking for a Medical Writing Document Manager to work as an insourced employee for a pharmaceutical company in redaction and anonymization activities of clinical research documents. The clinical documents prepared by the company’s Medical Writing group and clinical teams are required by certain Health Authorities to be posted in public domain […]

Read more

ADIAL: The Phase 3 ONWARD™ trial meets its screening target and nears enrollment completion

July 6, 2021 Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) announced that the Company has made significant progress on its pivotal ONWARD Phase 3 clinical trial having met 100% of its patient screening target and having achieved 90% of its patient enrollment target. The ONWARD trial is evaluating AD04 as a therapeutic agent for the treatment […]

Read more

Promising results from clinical trial for the treatment of Celiac Disease

Dr. Falk Pharma GmbH and Zedira GmbH have announced successful completion of the phase 2a clinical trial of ZED1227, a direct-acting and specific inhibitor of tissue transglutaminase, in patients with celiac disease. The clinical trial demonstrated a substantial protective effect of the first-in-class drug candidate ZED1227 on the duodenal mucosa during a 6-week gluten challenge. […]

Read more

Happy Clinical Trials Day

Each year on the 20th of May, World Clinical Trial Day is celebrated around the world. Find out about our journey by watching this video. Enjoy!

Read more

Happy Easter

Celebrating Easter during a pandemic is certainly hard for us all. Without a doubt, the pandemic has had a more severe impact on people who live far away from their families and friends, and on those who are unfortunately lonely due to different reasons. It is the second time in a row that we celebrate […]

Read more

Crown CRO welcomes collaboration in clinical trials across Nordic borders

Pharma Industry Finland recently reported that the pharmaceutical industry invested 330 million euros in Finland during the year 2020, with an increase of almost 40 % from the previous year.  A great portion of the increased investments were due to clinical trials. During a conference arranged by the Swedish Association of the Pharmaceutical Industry (LIF) […]

Read more

Study nurse training – introducing a nationwide, fully web-based program (Crown CRO is proud to participate)

The first nationwide study nurse training program (worth four academic credits) is a joint effort by all five Finnish university hospitals and the member companies of Pharma Industry Finland. The approach to planning and the training itself are both completely web-based. Besides the team from the Hospital District of Helsinki and Uusimaa (HUS), the working […]

Read more

Crown CRO is proud to recognize World Cancer Day – a day of unification to combat cancer across the globe

Today, on the 4th of February is World Cancer Day. On this day, international and national cancer communities raise awareness to promote and facilitate dialogue and collaboration between cancer patients, researchers, health care professionals and decision-makers, in order to help cancer patients and deliver better patient outcomes. Thanks to breakthroughs in basic research, technological developments […]

Read more

Crown CRO is proud to be part of this type 1 diabetes vaccine First in Human trial!

Article in Finnish: https://yle.fi/uutiset/3-11696658

Read more

Medical knowledge is a crucial element in clinical trials

Drug development never stops; new molecules are clinically tested and currently available medicines on the market are constantly re-evaluated for new indications. Clinical testing of medical devices, as well as cell and gene therapies also occupy a substantial portion of clinical trials. All this means that the need for knowledge and expertise in Medical Affairs […]

Read more

Ensuring patient safety in clinical trials requires team effort

The development of new drugs and treatments is a long and complex process where clinical trials play a crucial role. Ensuring and maintaining the rights, wellbeing and safety of patients during clinical trial conduct is the number one priority for all parties involved. Pharmacovigilance is an essential part of the drug development process and patient […]

Read more

The expanding landscape of Immuno-Oncology – benefits and challenges

I am sure we all have been or will be touched by cancer at some level, at some point in our lives. Perhaps we have had a relative, a friend or a colleague, whose life has been affected by cancer – an incurable and devastating disease that has no mercy on anyone. Despite a substantial […]

Read more

Crown CRO’s second CRA training successfully completed

Last year, Crown CRO launched a CRA training program that has garnered enormous interest. This year’s CRA training program was arranged at the end of October. The aim of the training was to introduce the participants to the CRO world, help them navigate through the complex path of clinical trials and give them a deep […]

Read more

Rescuing a clinical study that has lost one or more of its wheels

An over 30-year long career within clinical research and development from both big pharma and international CROs has taught me that many clinical trials suffer from delays. An estimated 85% of all clinical trials will experience delays, with 94% being delayed by over a month.1 Thus, the financial impact can be significant, e.g. the long-term profitability […]

Read more

The best way to empower girls is through education

Every year on the 11th of October, the International Day of the Girl is celebrated around the world. Today, girls are more powerful than ever before. We see young female leaders entering different sectors of society and can witness many highly recognized and respected global movements led by strong and smart young ladies. Despite these […]

Read more

Crown CRO supports international students by offering mentoring to those interested in Clinical Research

The University of Helsinki has started a mentoring program (HelsinkiUNI International Talent Program (HITP)), which offers a unique opportunity to international students to get acquainted with Finnish companies and organizations.    We at Crown are very pleased to take part in this program and consider it a great opportunity for both the students and us. […]

Read more

Virtual clinical trials in the aftermath of COVID-19

The COVID-19 pandemic shocked us when we least expected it and impacted our lives in a way that we could never imagine. Technology-wise, it will be remembered as one of the key drivers of digital transformation throughout the history of mankind. The possibility of reducing traditional face-to-face interactions in clinical trials was heavily debated when […]

Read more

Crown CRO celebrates its 15th anniversary

It has been a privilege to operate in the clinical research field and to be at the forefront of developing new treatments to patients with unmet medical needs for 15 years. Our journey would not have been possible without our highly committed and enthusiastic employees, valuable customers and collaborators from different parts of the world.  […]

Read more

Crown CRO is proud to be part of the CoroPrevention Clinical Trial – a unique opportunity to evaluate personalized prevention in CHD.

Coronary Heart Disease (CHD) affects both men and women and remains the leading cause of premature death globally. Cardiovascular diseases are a huge burden especially on the EU economy, costing the EU more than 200 billion euros annually. The aging population and the number of people affected by CHD increase in the EU. Thus, novel […]

Read more

My Journey to Crown

I started working at Crown in September 2019, right after finishing my graduate studies in Translational Medicine at the University of Helsinki. For me, it was really a dream come true to get a fulltime job in the industry of my interest right out of the gates! In this blog, I aim to give a […]

Read more

Collaboration is the keyword of the moment in Coronavirus research

An elderly lady sits in her small room in a nursing home. At the age of 95, she has seen everything. But never before anything like this. Corona is everywhere. She is very conscious. But at the same time, it’s impossible for her to understand that there is no one to tell her why an […]

Read more

CRA Training Program 20-21.10 and 27-28.10.2020.

This course is fully booked! Building a better and healthier tomorrow is a goal shared by the entire world. We at Crown CRO are proud to do our part for achieving this important goal by, for example, sharing our skills and knowledge and promoting the entire industry.  One way to do this is to help […]

Read more

Crown ICH GCP E6(R2) Online Test in English

This Good Clinical Practice Online Test covers the ICH GCP international guideline. The Crown GCP Online Test has been recognised by the TransCelerate mutual recognition program for Good Clinical Practice Training. The content of the Crown GCP Online Test is up-to-date and follows the current International ICH GCP Guideline. Test content includes the main topics […]

Read more

Adial Pharmaceuticals Commences Phase 3 Trial of AD04 for Alcohol Use Disorder

Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW), a clinical-stage biopharmaceutical company focused on the development of treatments for addiction, today announced that it has commenced a Phase 3 pivotal clinical trial to investigate AD04 as a genetically targeted therapeutic agent for the treatment of Alcohol Use Disorder (AUD). The trial has initially started in Finland, where […]

Read more

Performing clinical trials and research in Sweden

It is often stated that we must make it more attractive to perform clinical trials and research in Sweden. This is a valid statement and ambition. However, several main actors within the global pharmaceutical industry see Sweden as an attractive country for clinical research with a good reputation: the industry readily cooperates with clinics and […]

Read more

Crown CRO launches a new CRA training program

Building a better and healthier tomorrow is a goal shared by the entire world. We at Crown CRO are proud to do our part for achieving this important goal by, for example, sharing our skills and knowledge and promoting the entire industry.  One way to do this is to help new, talented people enter the […]

Read more

Call for the new government to strengthen clinical research

Part of our mission at Crown CRO is to bring to market new, safer, and more effective medications, improve treatment outcomes, help advance medicine and, ultimately, create a healthier future. That is why we also wholeheartedly support the recent appeal for the new government to improve the conditions and resources for clinical research. The appeal […]

Read more

Two Crown CRO representatives selected to Pharma Industry Finland PIF’s expert groups

Two Crown CRO representatives have been selected to serve in Pharma Industry Finland PIF’s expert groups. Their term began in March. Crown CRO’s Chief Commercial Officer Päivi Itkonen was selected to the Real-World Data expert group and Clinical Research Manager Leena Hollfast to the Clinical Drug Trials expert group.

Read more

Sigrid Therapeutics AB Initiates a Clinical Trial of SiPore15™ for Treatment of Prediabetes with Engagement from Crown CRO

Stockholm, January 28th 2019 – Sigrid Therapeutics AB (Sigrid) and Crown CRO (Crown) today announced the initiation of the STAR clinical trial testing the efficacy and safety ofthe orally administered medical device, SiPore15™. The goal of this clinical trial is to demonstrate an improvement in measurements of metabolic disorder in patients with prediabetes and newly […]

Read more

Happy holidays from all of us at Crown CRO!

Happy holidays from all of us at Crown CRO!

Read more

Adial Pharmaceuticals Partners With Crown CRO to Begin Phase 3 Clinical Trials of AD04 for the Treatment of Alcohol Use Disorder

Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW), a clinical-stage biopharmaceutical company focused on the development of treatments for addiction, and Crown CRO, a contract research organization based in Finland, today announced Crown’s engagement to manage Adial’s Phase 3 clinical trial for AD04 for the treatment of alcohol use disorder (AUD). The FDA approved protocol for this […]

Read more

Finnish high-end expertise in drug research: The 2018 top talents in clinical drug trials awarded

[English summary of the announcement released by the Pharmaceutical Information Centre on 25 Oct 2018]  For the fifth time in a row, the Investigator, Study Nurse and CRA (Clinical Research Associate) of the Year were nominated by Finnish clinical research professionals. In a clinical drug trial, the investigator, study nurse and CRA form a study team, […]

Read more

Benefits of performing clinical trials in Lithuania

Time flies. This year marks the 17th anniversary of my career in the CRO business, and my 11th anniversary at Crown CRO. I started at Crown in March 2007, and in September the same year I was appointed Clinical Research Manager and Head of the Lithuanian office. In addition, I have been involved in developing […]

Read more

How did we become a full-service CRO?

A few days ago, I asked our Chief Commercial Officer what was behind the company’s decision a couple of years ago to invest in Data Management and Pharmacovigilance. Päivi was quiet for a while, like she quite often is before answering. “We saw the financial potential,” she then said in her laconic way. Retrospectively, it […]

Read more

THE GENERAL DATA PROTECTION REGULATION (GDPR) AT CROWN CRO OY

For Crown CRO data protection and privacy are a top priority. We are committed to handling data and respecting privacy with utmost care, as it is the key to our business.

Read more

Crown CRO implements Oracle Argus as its new safety database

We at Crown CRO are proud to announce taking the next step in Pharmacovigilance by implementing the ORACLE ARGUS safety database.   This enables us and our customers to: Make faster and better safety decisions with scientific querying and analytics Improve quality and efficiency through safety integration and automation Enhance compliance with E2B exchange and periodic reporting […]

Read more

It’s a Privilege to Work in Finland

Advanced legislation, high degree of digitalization and Finns with high level of commitment are the key benefits of Finland in clinical research.

Read more

Crown Data Services launched!

We at Crown CRO are proud to announce our newest addition to our service portfolio – Data Services – making us a truly Full-Service CRO! Crown CRO Data Services include full Data Management using Industry Compliant systems, Biostatistics & Programming together with Consulting, Planning and Study Design to Final Report in seamless cooperation with Clinical […]

Read more

Nordic Conference on Pediatric Medicines

Crown CRO is proudly sponsoring the 2nd Nordic Conference on Pediatric Medicines, taking place in Helsinki on 21-22 May 2018. If you wish to schedule a meeting with one of our experts during the conference, please contact Kaius Heinilä (kaius.heinila(at)crowncro.com).

Read more